DOCSLIB.ORG

Managing, Training and Exploring Anatomy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Managing, Training and Exploring Anatomy MANAGING, TRAINING AND EXPLORING ANATOMY - HABILITATION THESIS - Associate Professor STAN CRISTINEL IONEL, MD, PhD - 2019 - CONTENTS Abbreviations 3 Abstract 5 Rezumat 7 SECTION I - PROFESSIONAL, SCIENTIFIC AND ACADEMIC ACHIEVEMENTS 9 Brief overview of the academic carreer 9 CHAPTER 1. FROM HYPPOCRATES TO HARVEY - FROM FASCIES TO ARTERIES 12 1.1. State of the Art 12 1.2. Sustentaculum facies - everlasting facial youth 17 1.2.1. Introduction 17 1.2.2. Material and methods 22 1.2.3. Results 23 1.2.4. Discussions 35 1.2.5. Final remarks 40 1.3. Anatomic variations in arterries 40 1.3.1. Introduction 40 1.3.2. Material and methods 41 1.3.3. Results 42 1.3.4. Discussion 44 1.3.5. Final remarks 46 1.4. Anatomical substrate of peritoneal dialysis 47 1.4.1. Introduction 47 1.4.2. Material and methods 47 1.4.3. Results 49 1.4.4. Discussion 54 1.4.5. Final remarks 56 1.5. Perspectives in clinical applied embryology 57 1.5.1. Introduction 57 1.5.2. Material and method 58 1.5.3. Results 58 1.5.4. Discussion 62 1.5.5. Final remarks 64 CHAPTER 2. THE PHOENIX OF BONE RESTORATION – FROM PATHOLOGY TO ANATOMY 64 2.1. State of the Art 64 2.2. Plate osteosynthesis in tibial fractures 67 2.2.1. Introduction 67 2.2.2. Materials and methods 70 2.2.3. Results 71 2.2.4. Discussions 73 2.2.5. Final remark 74 2.3. New perspectives in shoulder prosthesis 75 2.3.1. Introduction 75 2.3.2. Material and methods 76 2.3.3. Results 79 2.3.4. Discussion 80 2.3.5. Final remarks 82 CHAPTER 3. MORPHOFUNCTIONAL AND APPLIED DEVELOPMENTAL RESEARCH ON THE ENDOCRINE SYSTEM 82 3.1 State of the art 82 3.2. Advances in endocrine pancreatic function research 85 3.2.1. Introduction 85 3.2.2. Materials and methods 87 3.2.3. Results 88 2.2.4. Discussion 95 3.2.5. Final remarks 97 3.3. From developmental endocrinology to clinical research 98 3.3.1. Introduction 98 3.3.2. Materials and methods 98 3.3.3. Results 99 3.3.4. Discussion 102 3.3.5. Final remarks 103 CHAPTER 4. THE PROPHECY OF SURVIVAL – ADVANCES IN TUMOURS FOLLOW UP 104 4.1. State of the Art 104 4.2. Colorectal evaluation, from an anatomic perpective 106 4.2.1. Introduction 106 4.2.2. Materials and methods 108 4.2.3. Results 109 4.2.4 Discussions 115 4.2.5. Final remarks 119 SECTION II. PLANS FOR FUTURE RESEARCH 120 SECTION III. REFERENCES 125 ABBREVIATIONS CRC Colorectal cancer SMAS Superficial musculo-aponeurotyc system CT Computed tomography MRI Magnetic resonance imaging ICCs Interstitial cells of Cajal α-SMA Α -smooth muscle actin ICC-MY Interstitial cells of Cajal intermuscular ICC-IM Interstitial cells of Cajal intramuscular ICC-SM Interstitial cells of Cajal submucosal ANO1 Anoctamin-1 NCCs Neural crest cells ETCs Endothelial tip cells PD Peritoneal dialysis FOA Fronto-orbital artery ACA Anterior cerebral artery ACoA Anterior communicating artery ARFOA Aberrant right fronto-orbital artery BCP Biphasic tricalcium phosphate ORIF Open Reduction and Internal Fixation CPC Phosphocalcic cements CaP Calcium phosphates HA Hydroxyapatite SEM Scanning electron microscope CS Chitosan medium molecular weight TPP Sodium tripolyphosphate DMSO Dimethylsulfoxide CS-M Chitosan-metformin CS-MG Chitosan-metfomin-glybenclamide CS-G Chitosan-glybenclamide FT-IR Fourier transform infrared SD Swelling degree SGF Simulated gastric fluid TEM Transmission electron microscopy STZ Streptozotocin GBM Glomerular basement membrane F Females M Males G Group 3 PDD Peritoneal dyalisis duration - years MD Mesothelial denudation STF Submesothelial stromal fibrosis FD Fibrin deposits SVH Subendothelial vascular hyalinosis VP Vascular permeability PI Perivascular inflammation Ca Calcification ESRD End stage renal disease AKI Acute kidney injury 4 ABSTRACT A habilitation thesis brings autobiographical evidence of the background of the main results in postdoctoral scientific, didactic and professional activity. It also highlights the perspectives which this background open. Academic carreer is a complex profession, which lays its success on persuasion and self-improvement, creativity and a continous search for new ideas and concepts. The gross part of my academic career have been running under the sign and perspective of scientific research opportunity. I undiluted my work on two major goals: the research of different anatomical structures and scholar and research theme which is largely addressed to the pedagogical management of students and young practitioners. My work in the Anatomy Chair has also been focused on selection and motivation of the new coworkers and to stimulate and encourage future physicians to explore these themes. The leading perspectives of my professional career are to pursue research in the two major directions already mentioned. Entire efforts made accomplishing scholarship results are about to permanently update our syllabus and to synchronize it with the one of the European Union countries. This will improve the performance of our students and our international visibility, with a huge socio-economic impact. The inducement in the research activity started with the graduation of my PhD, under the coordination of Mircea Chiriac MD PhD. The theme of my doctoral thesis was "The systemic and telomic study of the external carotid system". My academic activity materialized in approaching the most social and medical demanding current dissorders. Following this direction we have conceived and published a total of 28 scientific in extenso manuscripts which gave me the right to participate in a number of 3 grant research projects. My habilitation thesis is organised in the three major SECTIONS required by the CNATDCU, as recommended and approved criteria. The manuscript presents my entire postdoctoral academic activity within the Chair of Anatomy at ‗Gr or T Pop ‘ Un v rs ty o M n n P rm y n I SECTION I includes the abstract of the thesis. SECTION II is divided into two distinguished parts: overview of personal, professional, academic and scientific achievements and a second part formed by another four chapters. The first part is a biographical record of the most significant features of my professional achievements in all the fields of academic activity. They are the consistence of the background and the skillfulness which enable me to achieve the top of the academic career. The second part comes out of my studies performed after I graduated the PhD research, including all the projects I have conducted. Thus, in its CHAPTER 1, entitled FROM HYPPOCRATES TO HARVEY - FROM FASCIES TO ARTERIES I discuss about the disseminated research of my work in morphofunctional approach of fascias, skeletal muscle and arterial anatomical variants. 5 By the CHAPTER 2, entitled THE PHOENIX OF BONE RESTORATION - FROM PATHOLOGY TO ANATOMY I approach the current issue of osteosynthesis which affects so many orthopedic patients. This study is conducted in order to assess the biocompatibility, quality and extent of osseous healing of modern days synthetic bone substitutes. CHAPTER 3, entitled MORPHOFUNCTIONAL AND APPLIED DEVELOPMENTAL RESEARCH ON THE ENDOCRINE SYSTEM undergoes the theme of the morphofunctional study on pancreatic endocrine system. It contains also, the results of a research project I have managed in laboratory study of diabetes mellitus type 2. The last one, CHAPTER 4, entitled THE PROPHECY OF SURVIVAL - ADVANCES IN TUMOUR TRACKING approaches the issue of early diagnosis, staging and management of colorectal tumours. This theme has also a huge social and economic impact because colorectal malignancies have an increased incidence and became one the most common cause of death by cancer. The purpose of the study is to evaluate the efficiency in use of neoangiogenesis biochemical markers and different radiologic high-end techniques in order to assess early informations about tumour proliferation rate and the prognosis of the patients. All my scientific achievements so far have been outlined in books and book chapters, ISI articles in journals with impact factor and communications at congress and conferences. These would not have been possible without teamwork within Anatomy Chair and would not have been possible without the help and signature of the medical school trainers. The continuity in studying the arterial system, started with the topic of my doctoral study, opened the way for my research career and empowered me with compulsory skills of an academic carreer. The achievements of my academic activity enhance the international visibility and the reputation of the University I am part of. SECTION III presents in a detailed manner all the perspectives that my former academic activity has opened. There are described all my plans for future researches in chronological order of the originating idea. Following this thinking I started to present the subjects from the PhD studies and I finished with the most recent ones. In the last part of the habilitation thesis I added the most significant and outstanding literature works that I used in my career as a fundamental starting point for my research. 6 REZUMAT O t ză b l t r u ov utob o r ă a fundamentului principalelor r zult t în t v t t șt nț ă, t ă ș pro s on lă post o tor lă D s m n , subl n ză p rsp t v l p r st un m nt l s C r r m ă st o profesiune ompl xă, r îș ăs șt su sul în t rm n r ș uto păș r , creativitate ș ăut r ont nuă unor ș on pt no Majoritatea carierei mele academice s- s ășur t sub s mnul ș p rsp t v oportun tăț a realiza o r t r șt nț ă M - m r ț on t mun p ouă obiective m jor : r t r r t lor stru tur n tom ș temei de cercetare r s r s ză în m r măsură m n m ntulu l s stu nț ș al tinerilor practicieni.
Load more

Recommended publications
  • Classification of Cell Death
    Cell Death and Differentiation (2005) 12, 1463–1467 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd News and Commentary Classification of cell death: recommendations of the Nomenclature Committee on Cell Death G Kroemer*,1, WS El-Deiry2, P Golstein3, ME Peter4, D Vaux5, with or without, caspase activation and that ‘autophagic cell P Vandenabeele6, B Zhivotovsky7, MV Blagosklonny8, death’ represents a type of cell death with (but not necessarily W Malorni9, RA Knight10, M Piacentini11, S Nagata12 and through) autophagic vacuolization. This article details the G Melino10,13 2005 recommendations of NCCD. Over time, molecular definitions are expected to emerge for those forms of cell 1 CNRS-UMR8125, Institut Gustave Roussy, 39 rue Camille-Desmoulins, death that remain descriptive. F-94805 Villejuif, France 2 University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA Preface 3 Centre d’Immunologie INSERM/CNRS/Universite de la Mediterranee de Marseille-Luminy, Case 906, Avenue de Luminy, 13288 Marseille Cedex 9, It is obvious that clear definitions of objects that are only France shadows in Plato’s cage are difficult to be achieved. Cell death 4 The Ben May Institute for Cancer Research, University of Chicago, 924 E 57th and the different subroutines leading to cell death do not Street, Chicago, IL 60637, USA 5 escape this rule. Even worse, the notion of death is strongly Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, influenced by religious and cultural beliefs, which may UK 6 Molecular Signalling and Cell Death Unit, Department for Molecular Biomedical subliminally influence the scientific view of cell death.
    [Show full text]
  • 4 Mitotic Catastrophe
    4 Mitotic Catastrophe Fiorenza Ianzini, FI, PhD, and Michael A. Mackey, MAM, PhD Summary Mitotic catastrophe (MC) is the result of premature or inappropriate entry of cells into mitosis, usually occurring because of chemical or physical stresses. MC is characterized by changes in nuclear morphology and the eventual appearance of polyploid cell progeny in affected cell populations, is markedly enhanced in cells lacking p53 function, and is the result of overaccumulation of cyclin B1 in cells delayed late in the cell cycle by the inducing agent. Thus, MC is considered to be the predominant mechanism underlying mitotic-linked cell death. Along with characteristic features associated with MC, a delayed DNA damage phenotype has been noted in these populations, suggesting a potential role for MC in mutagenesis and the acquisition of genomic instability. Although generally lethal, some cells can survive MC through mechanisms that are incompletely understood. Cytological features associated with meiotic cell division have been noted in polyploid cell populations produced through MC, a finding that might be particularly relevant in the understanding of tumor progression and that might provide a novel mechanism for the generation of quasi-diploid progeny from MC-induced polyploid cell populations. This review summarizes the literature pertaining to MC and describes current lines of research in this interesting research area. Key Words: Mitotic catastrophe; cell cycle regulation; cyclin B1; endopoly- ploid cells; mitosis; meiosis; carcinogenesis; tumor progression; delayed DNA damage; SPCC. 1. MOLECULAR MECHANISMS UNDERLYING MITOTIC CATASTROPHE 1.1. Mitotic Catastrophe is the Result of Premature Entry into Mitosis Following Abrogation of G2/M Checkpoint Function Exposure of some cell types to a broad class of agents can lead to a loss of regulation of cell division, such that cells enter into a premature mitosis, an event that culminates in a phenomenon called mitotic catastrophe (MC).
    [Show full text]
  • Radioimmunotherapy Effector Mechanisms
    UMEÅ UNIVERSITY MEDICAL DISSERTATIONS New Series No 1002 ISSN 0346-6612 ISBN 91-7264-013-8 ____________________________________________________ EXPERIMENTAL RADIOIMMUNOTHERAPY AND EFFECTOR MECHANISMS David Eriksson Departments of Immunology, Diagnostic Radiology and Radiation Physics Umeå University, Sweden Umeå 2006 The articles published in this thesis have been reprinted with permission from the publishers Copyright © 2006 by David Eriksson ISBN 91-7264-013-8 Printed in Sweden by Solfjädern Offset AB, Umeå 2006 ABSTRACT Experimental Radioimmunotherapy and Effector Mechanisms Radioimmunotherapy is becoming important as a new therapeutic strategy for treatment of tumour diseases. Lately monoclonal antibodies tagged with radionuclides have demonstrated encouraging results in treatment of hematological malignancies. The progress in treatment of solid tumours using radioimmunotherapy, however, has been slow. New strategies to improve the treatment response need to be evaluated. Such new strategies include the combination of radioimmunotherapy with other treatment modalities but also elucidation and exploration of the death effector mechanisms involved in tumour eradication. As the combination of radioimmunotherapy and radiotherapy provides several potential synergistic effects, we started out by optimising a treatment schedule to detect benefits combining these treatment modalities. An anti-cytokeratin antibody labelled with 125I administered before, after, or simultaneously with radiotherapy, indicated that the highest dose to the tumour was delivered when radiotherapy was given prior to the antibody administration. The optimised treatment schedule was then applied therapeutically in an experimental study on HeLa Hep2 tumour bearing nude mice given radiotherapy prior to administration of 131I-labelled monoclonal antibodies. Combining these treatment regimes enhanced the effect of either of the treatment modalities given alone, and a significant reduction in tumour volumes could be demonstrated.
    [Show full text]
  • Cell Death by Mitotic Catastrophe: a Molecular Definition
    Oncogene (2004) 23, 2825–2837 & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $25.00 www.nature.com/onc Cell death by mitotic catastrophe: a molecular definition Maria Castedo1, Jean-Luc Perfettini1, Thomas Roumier1, Karine Andreau1, Rene Medema2 and Guido Kroemer*,1 1CNRS-UMR 8125, Institut Gustave Roussy, Pavillon de Recherche 1, 39 rue Camille-Desmoulins, Villejuif F-94805, France; 2Division of Molecular Biology H8, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands The current literature is devoid of a clearcut definition of mutant strains (Molz et al., 1989; Ayscough et al., mitotic catastrophe, a type of cell death that occurs during 1992). Accordingly, some authors view ‘mitotic mitosis. Here, we propose that mitotic catastrophe results catastrophe’ of mammalian cells as the failure to from a combination of deficient cell-cycle checkpoints (in undergo complete mitosis (which would be more particular the DNA structure checkpoints and the spindle accurately called ‘mitotic failure’) after DNA damage assembly checkpoint) and cellular damage. Failure to (coupled to defective checkpoints), a situation that arrest the cell cycle before or at mitosis triggers an would lead to tetraploidy (after a single cell cycle) attempt of aberrant chromosome segregation, which (Andreassen et al., 2001a; Margottin-Goguet et al., culminates in the activation of the apoptotic default 2003) or endopolyploidy (after several cell cycles) with pathway and cellular demise. Cell death occurring during extensive DNA damage and repair, perhaps followed by the metaphase/anaphase transition is characterized by the the selection of apoptosis-resistance cells that will ulti- activation of caspase-2 (which can be activated in response mately survive after endoreduplication (Ivanov et al., to DNA damage) and/or mitochondrial membrane per- 2003).
    [Show full text]
  • Oral Presentations 2015 AANS Annual Scientific Meeting Washington, DC • May 2–6, 2015 (DOI: 10.3171/2015.8.JNS.Aans2015abstracts)
    Oral Presentations 2015 AANS Annual Scientific Meeting Washington, DC • May 2–6, 2015 (DOI: 10.3171/2015.8.JNS.AANS2015abstracts) 500. Pre‑ and Postoperative Skin Preparation Using past decade. Diagnosis related group‑associated variables assessed Chlorhexidine‑Alcohol in Patients Undergoing Lumbar within our analysis included for traumatic stupor and coma 1) total Instrumented Fusion: Results of a Novel Antisepsis Protocol number of discharges, 2) length of stay, 3) charges, and 4) hospital type. Peter C. Gerszten, MD, MPH, FAANS; Erin Paschel; Ramesh Results: In 1997, there were a recorded 18,891 discharges Grandhi, MD; David Okonkwo, MD, PhD; Adam Kanter, MD; for the treatment of traumatic stupor and coma nationally (2:1, Yue‑Fang Chang, PhD (Pittsburgh, PA) male:female ratio). The majority of children treated were at teaching institutions (60.0%) in large metropolitan centers (92.6%). 52.6% Introduction: Wound infection following lumbar instrumented of cases received care at a designated children’s hospital. Median fusion surgery is a potentially preventable complication that is length‑of‑stay was 1.0 days and median charges totaled $3,919. associated with major morbidity and cost. The purpose of this In comparison, 14,778 pediatric patients were treated for the same investigation was to demonstrate that the postoperative application presentation in 2012 (2.2:1, male:female ratio). Similar trends were of a skin antiseptic agent in addition to standard preoperative skin noted in the presentation to predominantly large, metropolitan preparation reduces surgical site infection. The study was also teaching institutions. However, only one‑quarter of such cases designed to identify risk factors for the development of infection in received care at a designated children’s hospital.
    [Show full text]
  • Mitotic Catastrophe
    Cell Death and Differentiation (2008) 15, 1153–1162 & 2008 Nature Publishing Group All rights reserved 1350-9047/08 $30.00 www.nature.com/cdd Review Death through a tragedy: mitotic catastrophe H Vakifahmetoglu1, M Olsson1 and B Zhivotovsky*,1 Mitotic catastrophe (MC) has long been considered as a mode of cell death that results from premature or inappropriate entry of cells into mitosis and can be caused by chemical or physical stresses. Whereas it initially was depicted as the main form of cell death induced by ionizing radiation, it is today known to be triggered also by treatment with agents influencing the stability of microtubule, various anticancer drugs and mitotic failure caused by defective cell cycle checkpoints. Although various descriptions explaining MC exist, there is still no general accepted definition of this phenomenon. Here, we present evidences indicating that death-associated MC is not a separate mode of cell death, rather a process (‘prestage’) preceding cell death, which can occur through necrosis or apoptosis. The final outcome of MC depends on the molecular profile of the cell. Cell Death and Differentiation (2008) 15, 1153–1162; doi:10.1038/cdd.2008.47; published online 11 April 2008 Historical Remarks defective cell cycle checkpoints.8 MC was also depicted as the main form of cell death induced by ionizing radiation. During mitosis, proliferating cells undergo several structural The first observations of MC were made in the late 1930s and molecular changes, characterized by chromatin conden- and early 1940s when cells in exponential growth phase were sation, spindle formation, nuclear envelope fragmentation and exposed to radiation.9,10 It was noticed that the fraction of cells cytoskeleton reorganization.1 Chromosome segregation is in the mitotic stage instantly declined in response to radiation carried out by a complex machinery – the mitotic spindle – that and did not reappear until several hours following treatment.
    [Show full text]
  • Chromosomal Breaks During Mitotic Catastrophe Trigger Γh2ax–ATM–P53-Mediated Apoptosis
    © 2017. Published by The Company of Biologists Ltd | Journal of Cell Science (2017) 130, 3419 doi:10.1242/jcs.210682 PUBLISHER’SNOTE Publisher’s Note: Chromosomal breaks during mitotic catastrophe trigger γH2AX–ATM–p53-mediated apoptosis. Gabriela Imreh, Helin Vakifahmetoglu Norberg, Stefan Imreh, Boris Zhivotovsky. J. Cell Sci. doi: 10.1242/jcs.081612 Michael Way Editor-in-Chief, Journal of Cell Science ([email protected]) This Publisher’s Note updates and replaces the Expression of Concern (J. Cell Sci. 2017 130, 1979; doi: 10.1242/jcs.205559) relating to the article ‘Chromosomal breaks during mitotic catastrophe trigger γH2AX–ATM–p53-mediated apoptosis’ by Gabriela Imreh, Helin Vakifahmetoglu Norberg, Stefan Imreh and Boris Zhivotovsky. J. Cell Sci. 2011 124, 2951-2963 (doi: 10.1242/jcs.081612). Concerns were raised regarding some of the data in Fig. 1A of the above-named paper. An investigation carried out by Karolinska Institutet concluded that no wrongdoing had occurred, and that no further action was required. An in-house review of the original data by Journal of Cell Science reached a similar conclusion. Journal of Cell Science is publishing this Note to alert readers that the concerns raised about this paper have been resolved. This course of action follows the advice set out by COPE (Committee on Publication Ethics), of which Journal of Cell Science is a member. Accepted manuscript • Journal of Cell Science 3419 © 2017. Published by The Company of Biologists Ltd | Journal of Cell Science (2017) 130, 1979 doi:10.1242/jcs.205559 PUBLISHER’SNOTE Expression of Concern: Chromosomal breaks during mitotic catastrophe trigger γH2AX–ATM–p53-mediated apoptosis.
    [Show full text]
  • Optimizing Experimental Radioimmunotherapy - Investigating the Different Mechanisms Behind Radiation Induced Cell Deaths
    Optimizing experimental radioimmunotherapy - Investigating the different mechanisms behind radiation induced cell deaths Theres Lindgren Department of Clinical Microbiology Umeå 2013 Responsible publisher under swedish law: the Dean of the Medical Faculty This work is protected by the Swedish Copyright Legislation (Act 1960:729) ISBN: 978-91-7459-717-2 ISSN: 0346-6612-1594 Front cover: Print & Media, Illustration: Imunohistochemical stainings of centrosomes and mitotic spindles in irradiated cells. Electronic version available at http://umu.diva-portal.org/ Printed by: Print & Media, Umeå Umeå, Sweden 2013 “The fact of evolution is the backbone of biology, and biology is thus in the peculiar position of being a science founded on an unproved theory - is it then a science or a faith?” — L.H. Matthews, The Origin of Species To my family Table of Contents Table of Contents i Abstract iii Svensk sammanfattning Fel! Bokmärket är inte definierat. Abbreviations viii List of papers in the thesis ix 1. Introduction 1 1.1 Carcinogenesis 1 1.2 The hallmarks of cancer 3 1.2.1 Mutation and genome instability 4 1.2.2 Inflammation 5 1.2.3 Evading apoptosis 5 1.2.4 Resisting growth suppression 6 1.2.5 Gain of proliferative signaling 7 1.1.6 Replicative immortality 7 1.2.7 Ability to invade and metastasize 8 1.2.8 Angiogenesis induction 9 1.2.9 Deregulation of cellular energetics 9 1.2.10 Evading the immune system 10 1.2 Treatment of cancer diseases 10 1.2.1 Radiotherapy 11 1.2.1.1 Radioimmunotherapy 11 1.3.1 The cell cycle phases 12 1.3.2 Cyclins and Cyclin dependent kinases 14 1.3.3 The centrosome cycle 15 1.4 DNA damage response 18 1.4.1 P53 19 1.4.2 Cell cycle arrests 20 1.4.1.1 G1 and intra-S arrest 20 1.4.1.2 G2 arrest 21 1.4.1.3 The spindle assembly checkpoint 21 1.4.3 DNA Repair 21 1.4.4 Life and death decisions 22 1.4.3.1 Apoptosis 22 1.4.3.2 Necrosis/Necroptosis 24 1.4.3.3 Senescence 24 1.4.3.4 Mitotic catastrophe 26 2.
    [Show full text]
  • Cell Death by Bortezomib-Induced Mitotic Catastrophe in Natural Killer Lymphoma Cells
    3807 Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells Lijun Shen,1 Wing-Yan Au,2 Kai-Yau Wong,1 higher pharmacologic concentrations of bortezomib. Norio Shimizu,3 Junjiro Tsuchiyama,4 Hence, activating mitotic catastrophe by bortezomib Yok-Lam Kwong,2 Raymond H. Liang,2 may provide a novel therapeutic approach for treating and Gopesh Srivastava1 apoptosis-resistant NK-cell malignancies and other can- cers. [Mol Cancer Ther 2008;7(12):3807–15] Departments of 1Pathology and 2Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, People’s Republic Introduction of China; 3Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; and 4Department of Pathology, According to the WHO classification scheme, natural killer Kawasaki Medical School, Kurashiki, Okayama, Japan (NK)-cell neoplasms include extranodal NK/T-cell lym- phoma (nasal type) and aggressive NK-cell leukemia (1). Theyare aggressive malignancies with poor treatment Abstract outcomes (2). The lymphoma cells are characteristically À The proteasome inhibitor bortezomib (PS-341/Velcade) is CD3 CD3q+CD56+ and are infected bythe EBV. NK-cell used for the treatment of relapsed and refractory multiple lymphomas show a geographic predilection, as they myeloma and mantle-cell lymphoma. We recently reported constitute 5% to 10% of all lymphomas in Asia and South its therapeutic potential against natural killer (NK)-cell America but are extremelyuncommon in the West. An neoplasms. Here, we investigated the molecular mecha- optimal treatment for NK-cell malignancies has yet to be nisms of bortezomib-induced cell death in NK lymphoma found (2). Radiotherapyof localized nasal NK-cell lym- cells.
    [Show full text]
  • Three Steps to the Immortality of Cancer Cells: Senescence, Polyploidy and Self-Renewal Jekaterina Erenpreisa1* and Mark S Cragg2
    Erenpreisa and Cragg Cancer Cell International 2013, 13:92 http://www.cancerci.com/content/13/1/92 REVIEW Open Access Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal Jekaterina Erenpreisa1* and Mark S Cragg2 Abstract Metastatic cancer is rarely cured by current DNA damaging treatments, apparently due to the development of resistance. However, recent data indicates that tumour cells can elicit the opposing processes of senescence and stemness in response to these treatments, the biological significance and molecular regulation of which is currently poorly understood. Although cellular senescence is typically considered a terminal cell fate, it was recently shown to be reversible in a small population of polyploid cancer cells induced after DNA damage. Overcoming genotoxic insults is associated with reversible polyploidy, which itself is associated with the induction of a stemness phenotype, thereby providing a framework linking these separate phenomena. In keeping with this suggestion, senescence and autophagy are clearly intimately involved in the emergence of self-renewal potential in the surviving cells that result from de-polyploidisation. Moreover, subsequent analysis indicates that senescence may paradoxically be actually required to rejuvenate cancer cells after genotoxic treatments. We propose that genotoxic resistance is thereby afforded through a programmed life-cycle-like process which intimately unites senescence, polyploidy and stemness. Keywords: Tumour cells, DNA damage, Senescence, Polyploidy, Self-renewal, Reprogramming, Totipotency, Resistance Introduction expression of senescence-associated β-galactosidase Accelerated cellular senescence (often simply termed (SA-β-gal) [7,8]. Hypertrophic senescent cells are also ‘senescence’) has been enigmatic since its first description. immunomodulatory and secrete cytokines [4].
    [Show full text]
  • MOS, Aneuploidy and the Ploidy Cycle of Cancer Cells
    Oncogene (2010) 29, 5447–5451 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 www.nature.com/onc REVIEW MOS, aneuploidy and the ploidy cycle of cancer cells J Erenpreisa1 and MS Cragg2 1Latvian Biomedicine Research and Study Centre, Riga, Latvia and 2Tenovus Laboratory, Cancer Sciences Division, Southampton University School of Medicine, General Hospital, Southampton, UK After DNA or spindle damage, p53-defective tumor cells the level of aneuploidy could be reduced in cancer cells undergo a complex cycle of reversible polyploidy. How (Vitale et al., 2010). In this study, isolated tetraploids, this process occurs and more importantly, why, has induced in diploid p53À/À HCT 116 colon cancer cells by recently become the focus of several research groups, nocodazole treatment, were shown to undergo multi- prompting this review in which we discuss two related polar and bipolar cell divisions accompanied by a phenomena that accompany the reversible polyploidy of gradual decrease in genomic instability and return to tumor cells: the induction of meiosis genes such as MOS para-diploidy over 2–3 weeks. The process was shown and the decrease in genomic instability observed during to be inhibited by functional p53. Intriguingly, the the reversion from polyploidy to para-diploidy. The isolated transition tetraploid clones enriched with the reversible polyploidy likely provides the means through reverted para-diploid fraction caused the most rapid which the balance between increased chromosome in- tumor growth when inoculated into nude mice. stability (CIN), driving genetic variation and decreased As such, the cells had undergone reversible polyploidy CIN, necessary for perpetuating these malignant clones, is (2n/4n/B2n), increasing and then suppressing the maintained.
    [Show full text]
  • DNA Damage-Induced Mitotic Catastrophe Is Mediated by the Chk1-Dependent Mitotic Exit DNA Damage Checkpoint
    DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint Xingxu Huang*, Thanh Tran*, Lingna Zhang*, Rashieda Hatcher*, and Pumin Zhang*†‡ *Departments of Molecular Physiology and Biophysics and †Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030 Communicated by Stephen J. Elledge, Harvard Medical School, Boston, MA, December 8, 2004 (received for review November 17, 2004) Mitotic catastrophe is the response of mammalian cells to mitotic so-formed binucleated cells are arrested in G1 in a p53-dependent DNA damage. It produces tetraploid cells with a range of different manner (12, 13). nuclear morphologies from binucleated to multimicronucleated. In It is unclear whether mammalian cells maintain a metaphase response to DNA damage, checkpoints are activated to delay cell DNA damage checkpoint that prevents securin degradation, as in cycle progression and to coordinate repair. Cells in different cell budding yeast, and whether DNA damage-induced mitotic catas- cycle phases use different mechanisms to arrest their cell cycle trophe is regulated by DNA damage checkpoints. We report here progression. It has remained unclear whether the termination of that, in contrast to budding yeast, mammalian securin is not mitosis in a mitotic catastrophe is regulated by DNA damage stabilized in response to mitotic DNA damage. Instead, there is a checkpoints. Here, we report the presence of a mitotic exit DNA mitotic exit DNA damage checkpoint that delays mitotic exit and damage checkpoint in mammalian cells. This checkpoint delays prevents cytokinesis, resulting in the formation of binucleated cells. mitotic exit and prevents cytokinesis and, thereby, is responsible for mitotic catastrophe.
    [Show full text]